## INTERIM MAINTENANCE I: AVERGE RISK ALL 

This therapy is for all patients with Average Risk B-ALL (post-Induction)

Interim Maintenance I begins when ANC ≥ 750/µL and platelets ≥ 75000/µL. This course lasts 8 weeks (56 days) and this Therapy Delivery Map is on one (1) page.

**VinCRIStine (VCR)**
-	Route: IV push over 1 minute
-	Dosage: 1.5 mg/m2/dose
-   Dilute with 10ml of 0.9% NaCl, IV infusion at 60ml/h
-	Used on Days 1, 11, 21, 31, & 41
-	Caution: Maximum dose: 2 mg

**Methotrexate (MTX)**
-	Route: IV push over 2-5 min or IV infusion over 10-15 mins
-	Dosage: Initial dose: 100mg/m2/dose; subsequent doses are increased by 50mg/m2/dose from the previous tolerated dose (previous dose must be provided)
-   Dilute with 0.9% NaCl to a target concentration of < 25 mg/mL, administer via IV infusion over 30 mins
-	Used on Days 1, 11, 21, 31, & 41
-	Caution: dosage is escalated over time 

**Intrathecal Methotrexate (IT MTX)**
-	Route: IT 
-	Dosage: 
    + Age (yrs) 1-1.99, dose 8 mg
    + Age (yrs) 2-2.99, dose 10 mg
    + Age (yrs) 3-8.99, dose 12 mg
    + Age (yrs) ≥9, dose 15 mg
    + Used on Day 31 ONLY